Targeting phenotypic heterogeneity in benign prostatic hyperplasia (Q88756540)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

title

Targeting phenotypic heterogeneity in benign prostatic hyperplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

prostatic hypertrophy

1 reference

inferred from title

phenotypic heterogeneity

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Daniel N Costa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

Franto Francis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

William A Ricke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

Claus G Roehrborn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

publication date

1 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

49-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases

27 March 2020

cites work

1 reference

12 December 2020

Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia

1 reference

12 December 2020

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia

1 reference

12 December 2020

Stromal nodules in benign prostatic hyperplasia: morphologic and immunohistochemical characteristics

1 reference

12 December 2020

Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property

1 reference

12 December 2020

In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme

1 reference

12 December 2020

Role of interleukins, IGF and stem cells in BPH

1 reference

12 December 2020

Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement

1 reference

12 December 2020

Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model

1 reference

12 December 2020

Molecular genetics of prostate cancer: new prospects for old challenges

1 reference

12 December 2020

Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging

1 reference

12 December 2020

Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.

1 reference

12 December 2020

UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

1 reference

12 December 2020

Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle

1 reference

12 December 2020

Effects of Tadalafil Once Daily on Maximum Urinary Flow Rate in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

1 reference

12 December 2020

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

1 reference

12 December 2020

Use of MRI for Lobar Classification of Benign Prostatic Hyperplasia: Potential Phenotypic Biomarkers for Research on Treatment Strategies

1 reference

12 December 2020

The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice

1 reference

12 December 2020

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study

1 reference

12 December 2020

Prostatic fibrosis, lower urinary tract symptoms, and BPH

1 reference

12 December 2020

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

1 reference

12 December 2020

Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin

1 reference

12 December 2020

Personalized medicine for the management of benign prostatic hyperplasia

1 reference

12 December 2020

Basal cell hyperplasia in the peripheral zone of the prostate

1 reference

12 December 2020

Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands

1 reference

12 December 2020

Medical treatment of benign prostatic hyperplasia

1 reference

12 December 2020

Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment

1 reference

12 December 2020

Definition of at-risk patients: dynamic variables

1 reference

12 December 2020

Stromal nodules in benign prostatic hyperplasia

1 reference

12 December 2020

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

1 reference

12 December 2020

Benign prostatic hyperplasia: a review and ultrasound classification

1 reference

12 December 2020

Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia

1 reference

12 December 2020

Human benign prostatic hyperplasia: A stromal disease? New perspectives by quantitative morphology

1 reference

12 December 2020

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

1 reference

12 December 2020

Magnetic resonance imaging of benign prostatic hyperplasia

1 reference

12 December 2020

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1 reference

12 December 2020

Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?

1 reference

12 December 2020

Revisiting the concept of cancer stem cells in prostate cancer.

1 reference

12 December 2020

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue

1 reference

12 December 2020

The anatomic heterogeneity of the prostate

1 reference

12 December 2020

Conserved two-step regulatory mechanism of human epithelial differentiation

1 reference

12 December 2020

Cell differentiation lineage in the prostate

1 reference

12 December 2020

Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia

1 reference

12 December 2020

Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

1 reference

12 December 2020

Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trials

1 reference

12 December 2020

Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.

1 reference

12 December 2020

Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations

1 reference

12 December 2020

Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size

1 reference

12 December 2020

Benign prostatic hyperplasia: a new metabolic disease?

1 reference

12 December 2020

The response of female urogenital tract epithelia to mesenchymal inductors is restricted by the germ layer origin of the epithelium: prostatic inductions

1 reference

12 December 2020

In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.

1 reference

12 December 2020

Clonal architecture of human prostatic epithelium in benign and malignant conditions

1 reference

12 December 2020

Prostatic fibrosis is associated with lower urinary tract symptoms

1 reference

12 December 2020

Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia

1 reference

12 December 2020

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

1 reference

12 December 2020

Epithelial-mesenchymal interactions in prostatic development. I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder

1 reference

12 December 2020

Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation

1 reference

12 December 2020

Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin

1 reference

12 December 2020

Recruitment of CD34( ) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

1 reference

12 December 2020

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network

1 reference

12 December 2020

The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype

1 reference

12 December 2020

Pathology of benign prostatic hyperplasia

1 reference

12 December 2020

Anatomy of the prostate and morphogenesis of BPH

1 reference

12 December 2020

Recent advances in the surgical treatment of benign prostatic hyperplasia

1 reference

12 December 2020

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

1 reference

12 December 2020

Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment

1 reference

12 December 2020

mRNA-Seq whole-transcriptome analysis of a single cell

1 reference

12 December 2020

Multipotent and unipotent progenitors contribute to prostate postnatal development

1 reference

12 December 2020

BPH gene expression profile associated to prostate gland volume

1 reference

12 December 2020

Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat.

1 reference

12 December 2020

Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia

1 reference

12 December 2020

Role of androgens and fibroblast growth factors in prostatic development

1 reference

12 December 2020

Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth

1 reference

12 December 2020

The zonal anatomy of the prostate

1 reference

12 December 2020

On the prediction of the histologic composition of benign prostatic hyperplasia based on clinical and MRI parameters

1 reference

12 December 2020

Improved Magnetic Resonance Imaging-Pathology Correlation With Imaging-Derived, 3D-Printed, Patient-Specific Whole-Mount Molds of the Prostate.

1 reference

12 December 2020

Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors

1 reference

12 December 2020

Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy

1 reference

12 December 2020

Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.

1 reference

12 December 2020

Benign nodular hyperplasia of the prostate; a review

1 reference

12 December 2020

The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected

1 reference

12 December 2020

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.

1 reference

12 December 2020

CD34 mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injury.

1 reference

12 December 2020

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

1 reference

12 December 2020

Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.

1 reference

12 December 2020

The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study

1 reference

12 December 2020

Economic costs of benign prostatic hyperplasia in the private sector.

1 reference

12 December 2020

The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.

1 reference

12 December 2020

The importance of stroma in morphogenesis and functional activity of urogenital epithelium

1 reference

12 December 2020

Definition of at-risk patients: baseline variables

1 reference

12 December 2020

A luminal epithelial stem cell that is a cell of origin for prostate cancer

1 reference

12 December 2020

New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States

1 reference

12 December 2020

Generation of a prostate from a single adult stem cell

1 reference

12 December 2020

Benign prostatic hyperplasia: value of MR imaging for determining histologic type

1 reference

12 December 2020

α-Blockers for benign prostatic hyperplasia: the new era.

1 reference

12 December 2020

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

1 reference

12 December 2020

An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia

1 reference

12 December 2020

Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial

1 reference

12 December 2020

Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)

1 reference

12 December 2020

Prostate stem cells and benign prostatic hyperplasia

1 reference

12 December 2020

Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and T

1 reference

12 December 2020

Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate

1 reference

12 December 2020

Steroid 5 alpha-reductase: two genes/two enzymes

1 reference

12 December 2020

Morphological analogies of fetal prostate stroma and stromal nodules in BPH

1 reference

12 December 2020

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model

1 reference

12 December 2020

Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006

1 reference

12 December 2020

The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study.

1 reference

12 December 2020

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

12 December 2020

Perivascular Gli1 progenitors are key contributors to injury-induced organ fibrosis.

1 reference

12 December 2020

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

1 reference

12 December 2020

Origin and evolution of benign prostatic enlargement

1 reference

12 December 2020

Sonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration

1 reference

12 December 2020

Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men

1 reference

12 December 2020

In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.

1 reference

12 December 2020

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms

1 reference

12 December 2020

Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

1 reference

12 December 2020

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

12 December 2020

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome

1 reference

12 December 2020

Morphometric quantitation of stroma in human benign prostatic hyperplasia

1 reference

12 December 2020

Prostate progenitor cells proliferate in response to castration

1 reference

12 December 2020

The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study

1 reference

12 December 2020

Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer

1 reference

12 December 2020

Spindle cell lesions of the adult prostate

1 reference

12 December 2020

Spatial reconstruction of single-cell gene expression data

1 reference

12 December 2020

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer

1 reference

12 December 2020

Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis

1 reference

12 December 2020

Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate

1 reference

12 December 2020

Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostates

1 reference

12 December 2020

Metabolic factors associated with benign prostatic hyperplasia

1 reference

12 December 2020

The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle

1 reference

12 December 2020

Urologic Diseases in America Project: Benign Prostatic Hyperplasia

1 reference

12 December 2020

Clinical effects of discontinuing 5-alpha reductase inhibitor in patients with benign prostatic hyperplasia

1 reference

12 December 2020

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

1 reference

12 December 2020

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

1 reference

12 December 2020

Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms

1 reference

12 December 2020

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

12 December 2020

Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer

1 reference

12 December 2020

Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism

1 reference

12 December 2020

Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms

1 reference

12 December 2020

The chimpanzee as a model of human benign prostatic hyperplasia.

1 reference

12 December 2020

The functional role of reactive stroma in benign prostatic hyperplasia

1 reference

12 December 2020

10.1016/J.DIFF.2017.07.005

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28800482 AND SRC:MED&resulttype=core&format=json

27 March 2020

PubMed publication ID

28800482

1 reference